Genscript Biotech Corp (GNNSF)
1.47
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Genscript Biotech Total Assets (Quarterly): 3.387B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.387B |
| June 30, 2023 | 3.384B |
| June 30, 2023 | 3.384B |
| December 31, 2022 | 2.546B |
| June 30, 2022 | 2.144B |
| June 30, 2022 | 2.144B |
| December 31, 2021 | 2.234B |
| June 30, 2021 | 1.888B |
| June 30, 2021 | 1.888B |
| December 31, 2020 | 1.448B |
| June 30, 2020 | 1.440B |
| June 30, 2020 | 1.440B |
| December 31, 2019 | 889.41M |
| Date | Value |
|---|---|
| June 30, 2019 | 881.95M |
| June 30, 2019 | 881.95M |
| December 31, 2018 | 916.98M |
| June 30, 2018 | 897.67M |
| June 30, 2018 | 897.67M |
| December 31, 2017 | 504.26M |
| June 30, 2017 | 245.56M |
| June 30, 2017 | 245.56M |
| December 31, 2016 | 226.03M |
| June 30, 2016 | 214.36M |
| June 30, 2016 | 214.36M |
| December 31, 2015 | 182.07M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
881.95M
Minimum
Jun 2019
3.387B
Maximum
Dec 2023
1.999B
Average
1.888B
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 13.66B |
| CASI Pharmaceuticals Inc | 75.27M |
| Zai Lab Ltd | 988.44M |
| Gracell Biotechnologies Inc (DELISTED) | 259.03M |
| Adagene Inc | 115.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.343B |
| Shareholders Equity (Quarterly) | 1.391B |
| Debt to Equity Ratio | 0.2474 |
| Current Ratio | 4.756 |
| Net Debt Paydown Yield | -0.95% |